«BioNTech» and «Pfizer» Have Started Testing the Vaccine on Children
OREANDA-NEWS. «BioNTech» and «Pfizer» Have Started Testing the Vaccine on Children. The research is expected to examine the safety, tolerability and effectiveness of the vaccine in the age group from six months to 11 years. According to the plan, the «BioNTech/Pfizer» drug will be used for children from the beginning of 2022. Earlier, the vaccine manufacturers «Moderna» and «AstraZeneca» announced the start of clinical trials of the vaccine on children.
Europe is facing a «new type of world war» in terms of vaccination campaigns. This was stated by French President Emmanuel Macron at a press conference following the first day of the EU video summit. The words of the head of state are quoted by the French newspaper «Le Figaro».
According to Macron, the threat is also «the desire of Russia and China to exert influence» through coronavirus vaccines. According to the French leader, the EU should demonstrate independence in the production of vaccines.
From December 1, 2020 to March 25, the European Union exported 77 million doses of the vaccine. This follows from the statement of the President of the European Commission (EC) Ursula von der Leyen, she made at a joint press conference with the President of the European Council Charles Michel following the video summit of the heads of EU countries. The document is cited by the press service of the EC.